UBCARE. CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,895 KRW | +2.41% |
|
+2.41% | +3.60% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,25,906 | 2,91,263 | 4,87,129 | 3,83,107 | 2,55,743 | 2,39,759 |
| Enterprise Value (EV) 1 | 1,58,690 | 2,18,438 | 4,25,410 | 3,17,661 | 2,14,507 | 2,07,835 |
| P/E ratio | 36.5 x | 43.2 x | 78.1 x | 28.8 x | 71.3 x | -140 x |
| Yield | 0.8% | 0.7% | 0.52% | 0.53% | 1.19% | 1.27% |
| Capitalization / Revenue | 2.25 x | 2.63 x | 4.52 x | 3.43 x | 1.92 x | 1.56 x |
| EV / Revenue | 1.58 x | 1.97 x | 3.95 x | 2.84 x | 1.61 x | 1.35 x |
| EV / EBITDA | 15 x | 15.1 x | 27 x | 24.6 x | 20.9 x | 23.5 x |
| EV / FCF | 25.3 x | 24.6 x | 54.4 x | 45.1 x | -708 x | -373 x |
| FCF Yield | 3.95% | 4.07% | 1.84% | 2.22% | -0.14% | -0.27% |
| Price to Book | 2.22 x | 2.84 x | 4.57 x | 3.25 x | 2.19 x | 2.28 x |
| Nbr of stocks (in thousands) | 51,342 | 50,743 | 50,743 | 50,743 | 50,743 | 50,743 |
| Reference price 2 | 4,400 | 5,740 | 9,600 | 7,550 | 5,040 | 4,725 |
| Announcement Date | 18/03/19 | 23/03/20 | 16/03/21 | 18/03/22 | 20/03/23 | 19/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,00,415 | 1,10,853 | 1,07,819 | 1,11,762 | 1,33,343 | 1,54,041 |
| EBITDA 1 | 10,590 | 14,447 | 15,756 | 12,904 | 10,242 | 8,831 |
| EBIT 1 | 9,158 | 12,354 | 13,409 | 9,654 | 6,413 | 3,446 |
| Operating Margin | 9.12% | 11.14% | 12.44% | 8.64% | 4.81% | 2.24% |
| Earnings before Tax (EBT) 1 | 7,711 | 10,857 | 9,229 | 15,842 | 6,092 | 1,941 |
| Net income 1 | 5,768 | 6,797 | 6,234 | 13,312 | 3,586 | -1,712 |
| Net margin | 5.74% | 6.13% | 5.78% | 11.91% | 2.69% | -1.11% |
| EPS 2 | 120.7 | 132.8 | 122.9 | 262.3 | 70.67 | -33.73 |
| Free Cash Flow 1 | 6,275 | 8,896 | 7,826 | 7,050 | -303.1 | -557.9 |
| FCF margin | 6.25% | 8.03% | 7.26% | 6.31% | -0.23% | -0.36% |
| FCF Conversion (EBITDA) | 59.25% | 61.58% | 49.67% | 54.63% | - | - |
| FCF Conversion (Net income) | 108.79% | 130.88% | 125.53% | 52.96% | - | - |
| Dividend per Share 2 | 35.00 | 40.00 | 50.00 | 40.00 | 60.00 | 60.00 |
| Announcement Date | 18/03/19 | 23/03/20 | 16/03/21 | 18/03/22 | 20/03/23 | 19/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 67,216 | 72,825 | 61,720 | 65,446 | 41,236 | 31,924 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 6,275 | 8,896 | 7,826 | 7,050 | -303 | -558 |
| ROE (net income / shareholders' equity) | 8.06% | 7.06% | 6.36% | 11.1% | 3.36% | 0.16% |
| ROA (Net income/ Total Assets) | 5.75% | 5.79% | 5.76% | 3.98% | 2.58% | 1.36% |
| Assets 1 | 1,00,277 | 1,17,388 | 1,08,201 | 3,34,687 | 1,39,190 | -1,25,924 |
| Book Value Per Share 2 | 1,980 | 2,021 | 2,099 | 2,323 | 2,300 | 2,071 |
| Cash Flow per Share 2 | 400.0 | 307.0 | 807.0 | 586.0 | 564.0 | 499.0 |
| Capex 1 | 738 | 1,047 | 2,000 | 884 | 1,555 | 1,335 |
| Capex / Sales | 0.74% | 0.94% | 1.86% | 0.79% | 1.17% | 0.87% |
| Announcement Date | 18/03/19 | 23/03/20 | 16/03/21 | 18/03/22 | 20/03/23 | 19/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +3.60% | 178M | |
| +18.46% | 342B | |
| +29.05% | 226B | |
| +9.88% | 159B | |
| +12.62% | 57.54B | |
| +18.76% | 35.74B | |
| +6.18% | 31.6B | |
| +166.92% | 30.64B | |
| +30.79% | 21.62B | |
| +43.15% | 14.97B |
- Stock Market
- Equities
- A032620 Stock
- Financials UBcare. Co., Ltd.